<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT05094726</url>
  </required_header>
  <id_info>
    <org_study_id>Rana H Elbanna</org_study_id>
    <nct_id>NCT05094726</nct_id>
  </id_info>
  <brief_title>Effect of PBM on Functional Capacity and Fatigability in Post Covid-19 Elderly</brief_title>
  <official_title>A Comparative Study Between Photobiomodulation and Placebo on Functional Capacity and Fatigability in Post Covid-19 Elderly</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Cairo University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Cairo University</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Participants had randomly divided into two equal groups. Group (A) which is the study group&#xD;
      will receive photobiomodulation session two times per week for four weeks. Group (B) will be&#xD;
      the control group that will receive placebo photobiomodulation two times per week for four&#xD;
      weeks.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      group (A):&#xD;
&#xD;
        1. Each participant will sign a consent form after receiving a detailed explanation about&#xD;
           the procedure.&#xD;
&#xD;
        2. submaximal exercise capacity using time up and go test will be assessed.&#xD;
&#xD;
        3. fatigability will be assessed using fatigue assessment scale.&#xD;
&#xD;
        4. hemodynamic variables including; Blood pressure, heart rate, oxygen saturation, maximum&#xD;
           oxygen consumption will also be assessed.&#xD;
&#xD;
        5. After one month all the assessment procedure will be repeated again.&#xD;
&#xD;
      r group (B):&#xD;
&#xD;
        1. Each participant will sign a consent form after receiving a detailed explanation about&#xD;
           the procedure.&#xD;
&#xD;
        2. submaximal exercise capacity using time up and go test will be assessed.&#xD;
&#xD;
        3. fatigability will be assessed using fatigue assessment scale.&#xD;
&#xD;
        4. hemodynamic variables including; Blood pressure, heart rate, oxygen saturation, maximum&#xD;
           oxygen consumption will also be assessed.&#xD;
&#xD;
        5. After one month all the assessment procedure will be repeated again.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">September 8, 2021</start_date>
  <completion_date type="Anticipated">November 15, 2021</completion_date>
  <primary_completion_date type="Anticipated">October 30, 2021</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <intervention_model_description>participants will divided into two equal groups , group A will receive photobiomodulation sessions and group B will receive placebo photobiomodulation</intervention_model_description>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Participant)</masking>
    <masking_description>participants</masking_description>
  </study_design_info>
  <primary_outcome>
    <measure>effect of photobiomodulation on fatigability level</measure>
    <time_frame>after one month of the trial application</time_frame>
    <description>fatigability level will be assessed using fatigability assesment scale</description>
  </primary_outcome>
  <primary_outcome>
    <measure>effect of photobiomodulation on functional capacity level</measure>
    <time_frame>after one month of the trial application</time_frame>
    <description>functional capacity state will be assessed using submaximal exercise test (time up and go test)</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">100</enrollment>
  <condition>Post Covid-19 Elderly</condition>
  <arm_group>
    <arm_group_label>Group A</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>the participant will received photobiomodulation session.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Group B</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>the participant will received placebo photobiomodulation session.</description>
  </arm_group>
  <intervention>
    <intervention_type>Radiation</intervention_type>
    <intervention_name>photobiomodulation</intervention_name>
    <description>Photobiomodulation (PBM) describes the use of red or near-infrared light to stimulate, heal, regenerate, and protect tissue that has either been injured, is degenerating, or else is at risk of dying.</description>
    <arm_group_label>Group A</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>placebo intervention by photobiomodulation device</intervention_name>
    <description>placebo intervention while the photobiomodulation device is on the off mode</description>
    <arm_group_label>Group B</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  60 to 75 years of age&#xD;
&#xD;
          -  past history of covid 19 in the last year&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  ( history of a histologically demonstrated malignant carcinoma , hyperthyreosis ,&#xD;
             epilepsy, light sensitivity )&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>60 Years</minimum_age>
    <maximum_age>75 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Rana H El Banna, PHD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Faculty of physical therapy at Cairo University</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Rana H El Banna, PHD</last_name>
    <phone>00201062070686</phone>
    <email>rana.elbanna@yahoo.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Sherif O Elabd, master</last_name>
    <phone>002001067227404</phone>
    <email>shiref.osama@yahoo.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Al Agouza Outpatient Clinic</name>
      <address>
        <city>Giza</city>
        <zip>12613</zip>
        <country>Egypt</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>sherif O osama, PHD</last_name>
      <phone>00201067227404</phone>
      <email>shiref.elabd@yahoo.com</email>
    </contact>
  </location>
  <location_countries>
    <country>Egypt</country>
  </location_countries>
  <verification_date>October 2021</verification_date>
  <study_first_submitted>October 23, 2021</study_first_submitted>
  <study_first_submitted_qc>October 23, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">October 26, 2021</study_first_posted>
  <last_update_submitted>October 23, 2021</last_update_submitted>
  <last_update_submitted_qc>October 23, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">October 26, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Cairo University</investigator_affiliation>
    <investigator_full_name>Rana Elbanna</investigator_full_name>
    <investigator_title>lecturer at faculty of physical therapy at Cairo University</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>COVID-19</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

